Skip to main content

Peer Review reports

From: Pyruvate anaplerosis is a mechanism of resistance to pharmacological glutaminase inhibition in triple-receptor negative breast cancer

Original Submission
13 Feb 2020 Submitted Original manuscript
17 Mar 2020 Reviewed Reviewer Report - Alex Shimura Yamashita
25 Mar 2020 Reviewed Reviewer Report - Alexander Muir
13 Apr 2020 Author responded Author comments - Dean Craig Singleton
18 Apr 2020 Author responded Author comments - Dean Craig Singleton
Resubmission - Version 2
13 Apr 2020 Submitted Manuscript version 2
Publishing
21 Apr 2020 Editorially accepted
25 May 2020 Article published 10.1186/s12885-020-06885-3

You can find further information about peer review here.

Back to article page